Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas. (Q54752976)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Tumour necrosis and microvascular proliferation are associated with 9p deletion and CDKN2A alterations in 1p/19q-deleted oligodendrogliomas. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

oligodendroglioma

1 reference

based on heuristic

inferred from title

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

author name string

Godfraind C

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Rousseau E

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Ruchoux MM

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Scaravilli F

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

publication date

1 October 2003

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Neuropathology and Applied Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

29

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

5

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

462-471

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Subtyping of oligo-astrocytic tumours by comparative genomic hybridization.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Histopathological-molecular genetic correlations in referral pathologist-diagnosed low-grade "oligodendroglioma".

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

The p16INK4a/CDKN2A tumor suppressor and its relatives.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

CDKN2A/p16 inactivation in the prognosis of oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Oligodendroglial tumors frequently demonstrate hypermethylation of the CDKN2A (MTS1, p16INK4a), p14ARF, and CDKN2B (MTS2, p15INK4b) tumor suppressor genes.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Concurrent inactivation of RB1 and TP53 pathways in anaplastic oligodendrogliomas.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Glioma classification: a molecular reappraisal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Molecular genetic aspects of oligodendrogliomas including analysis by comparative genomic hybridization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Prognostic value of the proliferation-related antigen Ki-67 in oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Vascular endothelial growth factor expression in oligodendrogliomas: a correlative study with Sainte-Anne malignancy grade, growth fraction and patient survival

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Vascular endothelial growth factor expression correlates with tumour grade and vascularity in gliomas.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the vasculature of oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2990.2003.00484.X

21 January 2018

Identifiers

10.1046/J.1365-2990.2003.00484.X

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14507338

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54752976&oldid=2070132576"